FDA Clearance Tracker · P980022-S104
MEDTRONIC MINIMED PARADIGM REAL-TIME REVEL PUMP, PARADIGM REAL-TIME PUMP, AND GUARDIAN REAL-TIME MONITOR
Last checked: Nov 20, 2026Latest source record: Mar 28, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2012
Approved
Time to decision
128 days
Received Nov 21, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980022-S104
- Device name
- MEDTRONIC MINIMED PARADIGM REAL-TIME REVEL PUMP, PARADIGM REAL-TIME PUMP, AND GUARDIAN REAL-TIME MONITOR
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Nov 21, 2011
- Decided
- Mar 28, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980022
Device type
- Device type
- Sensor, glucose, invasive (MDS)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL TO 1) ADD THE BAYER CONTOUR LINK WIRELESS METER TO THE LIST OF METERS, IN THE LABELING, THAT CAN COMMUNICATE WITH THE PARADIGM REAL-TIME REVEL SYSTEM (MMT-523, MMT-723, MMT-523K, MMT-723K); 2) ADD THE BAYER CONTOUR NEXT LINK WIRELESS METER TO THE LIST OF METERS , IN THE LABELING, THAT CAN COMMUNICATE WITH THE PARADIGM REAL-TIME REVEL SYSTEM (MMT-523, MMT-723, MMT-523K, MMT-723K), PARADIGM REAL-TIME SYSTEM (MMT-522, MMT-722, MMT-522K, MMT-722K), AND THE GUARDIAN REAL-TIME CONTINUOUS MONITORING SYSTEM (CSS7100, CSS7100K); AND 3) ENABLE THE BAYER CONTOUR NEXT LINK WIRELESS METER TO FACILITATE TRANSFER OF DATA FROM THE PARADIGM REAL-TIME REVEL SYSTEM (MMT-523, MMT-723, MMT-523K, MMT-723K), PARADIGM REAL-TIME SYSTEM (MMT-522, MMT -722, MMT -522K, MMT -722K}, AND THE GUARDIAN REAL-TIME CONTINUOUS MONITORING SYSTEM (CSS7100, CSS7100K) TO THE CARELINK THERAPY MANAGEMENT SOFTWARE (MMT-7333, MMT-7335) VIA THE METER USB PORT.
Source documents
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.